Business
No Borders, Inc. (Ticker:NBDR) Subsidiary MediDent Supplies Announces New Stay At Home 15 Minute COVID-19 Blood Tests
No Borders, Inc. (Ticker:NBDR) Subsidiary MediDent Supplies Announces New Stay At Home 15 Minute COVID-19 Blood Tests.
About this update from No Borders, Inc.
[{"type":"text","content":"\n Phoenix, AZ, March 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- No Borders, Inc. (OTC:NBDR), today announced that the Company has executed an agreement with its existing suppliers in Hong Kong to bring its 15 minute “At Home” Serological COVID-19 test to the USA.  The brand new “MediDent Supplies 15 Minute Rapid Result Covid-19 Test” is being manufactured by a MediDent Supplies partner with existing US FDA registrations for both the manufacturer and the serological test kit itself. MediDent Supplies is actively engaged with the FDA to obtain an Emergency Use Authorization for its COVID-19 blood test and the Company believes due to a recent update to the FDA COVID-19 testing guidelines which now include serological testing as an acceptable means of testing, that it will receive expedited approval for these tests very quickly.  MediDent Supplies has already purchased thousands of units of this test and has expedited Air Freight delivery of these tests to the USA in order to be fully ready to distribute them nationwide the moment the Company’s EUA is processed by the FDA. No Borders is actively engaged with the FDA, FEMA, Congressman Paul Gosar’s and Congressman Kevin McCarthy’s offices and is proud to have direct support from these and many other government members in its efforts to move quickly, deploy nationally and help Americans combat the COVID-19 epidemic. “Our entire team is committed to deploying every ounce of effort we can to help America through this trying time. Millions of people around the world have used these serological tests to identify COVID-19 antibodies in the blood and these tests will have a dramatic impact on America’s ability to scale national real time testing efforts with a proven, effective blood test,” said Joseph Snyder, CEO of MediDent Supplies. He continued, “Working quickly with our partners in Hong Kong and government officials here in the USA we have already purchased and expedited shipment of thousands of units of these tests. With the existing FDA registrations for our manufacturing partner and the test as a medical device in hand I believe that MediDent Supplies will be able to receive an expedited EUA from the FDA within weeks if not days. In order to mitigate lag time in bringing these critically nee...